Potassium, Calcium, and Phosphate Homeostasis


Learning Objectives

Upon completion of this chapter, the student should be able to answer the following questions :

  • 1

    How does the body maintain K + homeostasis?

  • 2

    What is the distribution of K + within the body compartments? Why is this distribution important?

  • 3

    What are the hormones and factors that regulate plasma K + levels? Why is this regulation important?

  • 4

    How do the various nephron segments transport K + and what mechanisms determine how much K + is excreted in the urine?

  • 5

    Why is the distal tubule and collecting duct important in regulating K + excretion?

  • 6

    How do plasma K + levels, aldosterone, vasopressin, tubular fluid flow rate, and acid-base balance influence K + excretion?

  • 7

    What is the physiological importance of calcium (Ca ++ ) and inorganic phosphate (P i )?

  • 8

    How does the body maintain Ca ++ and P i homeostasis?

  • 9

    What are the roles of kidneys, gastrointestinal tract, and bone in maintaining plasma Ca ++ and P i levels?

  • 10

    What hormones and factors regulate plasma Ca ++ and P i levels?

  • 11

    What are the cellular mechanisms responsible for Ca ++ and P i reabsorption along the nephron?

  • 12

    What hormones regulate renal Ca ++ and P i excretion by the kidneys?

  • 13

    What is the role of the calcium-sensing receptor?

  • 14

    What are the common clinical disorders of Ca ++ and P i homeostasis?

  • 15

    What is the role of the kidneys in the vitamin D metabolism?

  • 16

    What effects do loop and thiazide diuretics have on Ca ++ excretion?

  • 17

    What is the effect of chronic dietary potassium deficiency on blood pressure?

  • 18

    What are the effects of chronic total body K + depletion on kidney function?

K + Homeostasis

Potassium (K + ) is the most abundant cation in the body. The vast majority of total body K + is located intracellularly (98%) where the [K + ] is 150 mEq/L. Only 2% of total body K + exists in the ECF at a concentration of approximately 4 mEq/L. The large [K + ] difference across cell membranes (≈146 mEq/L) is maintained by the Na + ,K + -ATPase. The [K + ] gradient is important in maintaining the potential difference across cell membranes and is critical for the excitability of nerve and muscle cells, as well as for the contractility of cardiac, skeletal, and smooth muscle cells ( Fig. 36.1 ). Skeletal muscles contain the largest single pool of K + in the body. In an adult, the skeletal muscles contain approximately 225 times more K+ than all extracellular compartments in the body. Moreover, due to the large number of Na + ,K + -ATPase pumps and K + channels, skeletal muscles possess a huge capacity for K + exchange. Despite wide fluctuations of the dietary K + load, [K + ] remains remarkably constant in the intracellular fluid (ICF) and extracellular fluid (ECF). A [K + ] in ECF that exceeds 5.0 mEq/L constitutes hyperkalemia. Conversely, a [K + ] in ECF of less than 3.5 mEq/L constitutes hypokalemia. During hypokalemia, skeletal muscle cells release K + to preserve [K + ] in the ECF leading to total body K + depletion.

Fig. 36.1, Effects of variations in plasma [K + ] on resting membrane potential of skeletal muscle. Hyperkalemia causes membrane potential to become less negative, which decreases excitability by inactivating the fast Na + channels responsible for the depolarizing phase of the action potential. Hypokalemia hyperpolarizes the membrane potential and thereby reduces excitability because a larger stimulus is required to depolarize the membrane potential to the threshold potential. Resting indicates “normal” resting membrane potential. Normal threshold indicates the membrane threshold potential.

IN THE CLINIC

The K + level is usually determined from a venous blood sample. K + levels were traditionally measured in serum from coagulated blood, but are now more frequently measured in plasma from heparinized blood. Serum levels may generally be 0.2 to 0.4 mEq/L higher than plasma levels. Inappropriate blood sampling technique may affect the results. K + levels rise in the ECF after physical activity (see later). Thus blood sampling to measure K + should be done after several minutes of rest. Hemolysis of red blood cells during or after phlebotomy will release K + into plasma, thereby artificially elevating [K + ] in the collected blood sample. Only needles, tubes, and tube adaptors approved for K + measurements should be used to prevent hemolysis. A large vein should be used (e.g., the cubital vein) without fist clenching and without prolonged application of a tourniquet. Pseudohyperkalemia refers to potassium >5 mmol/L in the collection tube and normal K + level in patient’s blood. In addition to causing pseudohyperkalemia, errors of K + determination may conceal hypokalemia.

Hypokalemia may develop in people with chronic administration of diuretic, excessive use of laxatives, vomiting, eating disorders, or diarrheal illness. Gitelman syndrome (a genetic defect in the Na + /Cl cotransporter in the apical membrane of distal renal tubule cells) also causes hypokalemia (see Chapter 34 ). Hyperkalemia may occur in patients with renal failure, or as a side effect of medications such as angiotensin-converting enzyme (ACE) inhibitors and K + -sparing diuretics in patients with underlying kidney disease (decreased ability to renally excrete K + ), or in patients with diabetes mellitus (decreased ability to shift K + intracellularly).

IN THE CLINIC

Cardiac arrhythmias can result from hyperkalemia and hypokalemia. The electrocardiogram (ECG; Fig. 36.2 ) (also see Chapter 16 ) monitors the electrical activity of the heart and is a fast and reliable method to determine whether changes in plasma [K + ] influence the heart function. The first sign of hyperkalemia is the appearance of tall, thin T waves on the ECG. Further increases in plasma [K + ] prolong the PR interval, depress the ST segment, and lengthen the QRS interval of the ECG. As plasma [K + ] approaches 10 mEq/L, the P wave disappears, the QRS interval broadens, the ECG appears as a sine wave, and the ventricles fibrillate (i.e., manifest rapid, uncoordinated contractions of muscle fibers). Hypokalemia prolongs the QT interval, inverts the T wave, and lowers the ST segment of the ECG.

Fig. 36.2, Electrocardiographs from individuals with varying plasma [K + ]. See text for details.

K + absorbed from the gastrointestinal (GI) tract enters the ECF within minutes ( Fig. 36.3 ). If the K + ingested during a normal meal (≈33 mEq) were to remain in the ECF compartment (14 L) plasma [K + ] would increase by 2.4 mEq/L (33 mEq added to 14 L of ECF):


33 mEq/14 L = 2 . 4 mEq/L

Fig. 36.3, Overview of K + homeostasis. An increase in plasma insulin, epinephrine, or aldosterone stimulates movement of K + into cells and decreases plasma [K + ], whereas a fall in plasma concentration of these hormones has the opposite effect and increases plasma [K + ]. The amount of K + in the body is determined by the kidneys. An individual is in K + balance when dietary intake and urinary output (plus output by the GI tract) are equal. Excretion of K + by the kidneys is regulated by plasma [K + ], aldosterone, and arginine vasopressin (AVP) .

Rapid (seconds to minutes) intracellular uptake of K + is essential to prevent life-threatening hyperkalemia. Excretion of K + by the kidneys is relatively slow (hours). Maintaining total body [K + ] constant requires that almost all the K + absorbed from the GI tract is eventually excreted by the kidneys. The colon is responsible for the remaining small fraction of K+ excretion, and in patients with end-stage kidney disease the colon may increase fecal K + excretion.

Regulation of Plasma [K + ]

Several hormones, including epinephrine, insulin, and aldosterone, increase uptake of K + into skeletal muscle, liver, bone, and red blood cells ( Box 36.1 ; see Fig. 36.3 ) by stimulating Na + ,K + -ATPase and the Na + /K + /2Cl and Na + /Cl cotransporters in these cells. Acute stimulation of K + uptake (i.e., within minutes) is mediated by increased activity of existing Na + ,K + -ATPase and the Na + /K + /2Cl and Na + /Cl cotransporters, whereas a chronic increase in K + uptake (i.e., within hours to days) is mediated by increased abundance of Na + ,K + -ATPase. The rise in plasma [K + ] that follows K + absorption by the GI tract stimulates secretion of insulin from the pancreas, release of aldosterone from the adrenal cortex, and secretion of epinephrine from the adrenal medulla (see Fig. 36.3 ). In contrast, a decrease in plasma [K + ] inhibits release of these hormones. Whereas insulin and epinephrine act within a few minutes, aldosterone requires about an hour to stimulate uptake of K + into cells.

BOX 36.1
Major Factors, Hormones, and Drugs Influencing Distribution of K + Between Intracellular and Extracellular Fluid Compartments

Physiological: Keep Plasma [K + ] Constant

  • Epinephrine

  • Insulin

  • Aldosterone

Pathophysiological: Displace Plasma [K + ] From Normal

  • Acid-base disorders

  • Plasma osmolality

  • Cell lysis

  • Vigorous exercise

Drugs That Induce Hyperkalemia

  • Dietary K + supplements

  • ACE inhibitors

  • K + -sparing diuretics

  • Heparin

Epinephrine

Catecholamines affect the distribution of K + across cell membranes by activating α- and β 2 -adrenergic receptors. Stimulation of α-adrenoceptors releases K + from cells, especially in the liver, whereas stimulation of β 2 -adrenoceptors promotes K + uptake by cells.

For example, activation of β 2 -adrenoceptors after exercise is important in preventing hyperkalemia. The rise in plasma [K + ] after a K + -rich meal is greater if the patient has been pretreated with a β-adrenoceptor antagonist (e.g., propranolol). Furthermore, release of epinephrine during stress (e.g., myocardial ischemia) can rapidly lower plasma [K + ].

Insulin

Insulin is the most important hormone that shifts K + into cells after ingestion of dietary K + . Insulin and glucose infusion can be used to correct life-threatening hyperkalemia. In patients with diabetes mellitus (i.e., insulin deficiency), the rise in plasma [K + ] after a K + -rich meal is greater than in healthy people. In patients with chronic kidney disease, although insulin-stimulated glucose uptake into cells is impaired, insulin stimulation of K + uptake into cells is preserved.

Aldosterone

Aldosterone, like catecholamines and insulin, also promotes uptake of K + into cells. A rise in aldosterone levels (e.g., primary aldosteronism) causes hypokalemia, whereas a fall in aldosterone levels (e.g., Addison’s disease) causes hyperkalemia. As discussed later and as illustrated in Fig. 36.3 , aldosterone also stimulates urinary K + excretion. Thus aldosterone alters plasma [K + ] by acting on uptake of K + into cells and altering urinary K + excretion.

Alterations in Plasma [K + ]

Hyperkalemia usually develops when the amount of K + , either enteral (dietary or bleeding into the GI tract) or parenteral (intravenous administration or hemolysis), exceeds the ability of intracellular uptake and the kidneys to excrete K + (see Box 36.1 ). Hypokalemia usually develops when intracellular K + uptake and renal K + loss exceeds K + intake (dietary or intravenous) (see Box 36.1 ). In some situations (see later), changes in the distribution of K + between the ECF and ICF alone can result in acute and clinically relevant disturbances of plasma [K + ].

Acid-Base Balance

Metabolic acidosis increases plasma [K + ], whereas metabolic alkalosis decreases it. Respiratory alkalosis causes hypokalemia. In contrast, respiratory acidosis has little or no effect on plasma [K + ]. Metabolic acidosis produced by addition of inorganic acids (e.g., HCl, H 2 SO 4 ) increases plasma [K + ] much more than an equivalent acidosis produced by accumulation of organic acids (e.g., lactic acid, acetic acid, ketoacids). The reduced pH (i.e., increased [H + ]) promotes movement of H + into cells and the reciprocal movement of K + out of cells to maintain electroneutrality. This effect of acidosis occurs in part because acidosis inhibits the transporters that accumulate K + inside cells, including Na + ,K + -ATPase and the Na + /K + /2Cl cotransporter. In addition, movement of H + into cells occurs as the cells buffer changes in [H + ] of the ECF (see Chapter 37 ). As H + moves across cell membranes, K + moves in the opposite direction, and thus cations are neither gained nor lost across cell membranes. Metabolic alkalosis has the opposite effect; plasma [K + ] decreases as K + moves into cells and H + exits.

Although organic acids produce a metabolic acidosis, they do not cause significant hyperkalemia. Two explanations have been suggested for the reduced ability of organic acids to cause hyperkalemia. First, the organic anion may enter the cell with H + and thereby eliminate the need for K + -H + exchange across the membrane. Second, organic anions may stimulate insulin secretion, which moves K + into cells. This movement may counteract the direct effect of the acidosis, which moves K + out of cells.

You're Reading a Preview

Become a Clinical Tree membership for Full access and enjoy Unlimited articles

Become membership

If you are a member. Log in here